Detalhe da pesquisa
1.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161271
2.
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Ann Surg
; 277(1): e153-e161, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534229
3.
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
Gynecol Oncol
; 163(1): 64-71, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294414
4.
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Breast Cancer Res Treat
; 173(2): 397-406, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30357526
5.
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy.
Respir Med Res
; 84: 101012, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307617
6.
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohort.
J Geriatr Oncol
; 14(2): 101423, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657245
7.
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
Breast Cancer
; 30(2): 329-341, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630013
8.
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study.
Breast
; 65: 136-144, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944353
9.
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort.
Lung Cancer
; 162: 119-127, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775215
10.
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience.
Cancers (Basel)
; 14(1)2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008257
11.
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
Target Oncol
; 16(6): 801-811, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661827
12.
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
Ther Adv Med Oncol
; 13: 1758835920987657, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33613700
13.
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study.
Anticancer Res
; 40(7): 3905-3913, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620631
14.
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).
BMJ Open
; 9(2): e023568, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796119